A comparative review of developmental screening tests.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to T Stancin.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
To determine high school athletes' attitudes toward and use of ergogenic aids, we surveyed 295 students presenting for preparticipation examinations. In general, young athletes believed that steroids and amphetamines were not efficacious in enhancing sports performance and that their use was potentially harmful. Subjects reported minimal use of steroids (1%) and amphetamines (2%), and only a minority would consider their use. As a group, however, male athletes were more likely to believe that steroids were effective (32% vs 13%) and to consider the future use of these agents (14% vs 0) compared with female athletes. The majority of high school athletes believed that supplemental protein or vitamins could improve performance and that their use caused little or no health risk. These data suggest that young athletes may require information regarding the limited benefits and potential risks associated with the use of ergogenic aids.
Case reports and empirical studies suggest that young women with insulin-dependent diabetes mellitus (IDDM) may be at high risk for developing eating disorders. In this study, self-reports of binge eating and purging from 59 IDDM women (aged 18-30 yr) were obtained. Most participants (58%) reported that they went on eating binges, and 12% met the DSM-III criteria for a diagnosis of bulimia. Nearly 40% admitted to controlling their weight by insulin purging, and 13.5% reported purging by other means. A group of bulimic participants had mean scores on an eating disorder questionnaire in the pathological range. Bulimic symptoms were positively related to reports of hospitalizations, episodes of ketoacidosis, and psychological symptoms. Implications of these results on the medical management of young women with IDDM are discussed.
The duration of immunity following varicella-zoster vaccination in healthy children remains a critical issue. In a 3-year study of 140 OKA/Merck vaccine recipients, duration of immunity was assessed by two measures. The first was persistence of varicella-zoster antibody measured by modified fluorescent antibody to membrane antigen test. Thirty-six toddler vaccinees 12 to 24 months of age had sera obtained at 6 weeks, 1 year, and 2 years. Geometric mean titer +/- SD at 6 weeks was 57.7 +/- 2.9; at 1 year, it was 12.4 +/- 3.9; at 2 years, it was 9.9 +/- 3.9. Repeated-measures analysis of variance showed a significant overall decrease in antibody titer with time (F = 30.62, P less than .001). Post hoc comparisons indicated that the 6-week and 1-year titers were significantly different (P less than .001), but the difference between 1 and 2 years was not (P = .138). Clinical reinfections were also examined for 3 years after vaccination. Suspected varicella cases were confirmed by a fourfold or more increase in titer. Of 84 toddlers, 68 were exposed one or more times, and 6 became reinfected. Of 49 siblings, 45 were exposed, and one became reinfected. All 7 children had less than 70 vesicles and 6 of 7 were afebrile. No cases of zoster occurred. It is concluded that OKA/Merck varicella-zoster vaccination leads to antibody persistence for 2 years and the few reinfections that do occur are greatly attenuated.
Explore the source record for details and available documents.
Two studies were conducted to examine the validity of caregiver information on the developmental status of severely brain-damaged young children. First, developmental information on 106 severely brain-damaged young children, obtained from a caregiver-completed behavior inventory--the Kent Infant Development Scale, was compared to that obtained from the Bayley Scales of Infant Development (the Bayley Scales). Developmental age estimates from both tests were highly correlated and similar. Results suggest that it is possible to substitute the Kent Infant Development Scale for the Bayley Scales when measuring the developmental status of severely brain-damaged young children. In a second study examining the differential validity of caregivers' reports, we found that mothers' Kent Infant Development Scales yielded higher developmental age estimates than did teachers' Kent Infant Development Scales.